Spanish gene therapy specialist VIVEbiotech has named Patricio Massera as its new president, bringing in a seasoned CDMO ...

Veteran CDMO executive to guide next phase of global expansion and operational excellence for lentiviral vector manufacturer.

The Hopewell site is equipped to support clinical-stage development, process-development, and scaleup for cell and gene therapy programs.

Lentivirus as a vector in ex vivo gene therapy Lentiviral vectors have become highly popular for clinical applications due to their ability to transduce nonproliferating or slowly proliferating cells.

The 128,000 sq ft GMP facility is purpose-built for manufacturing high-quality plasmid DNA and viral vectors, including adeno-associated virus (AAV) and lentiviral vector (LVV) platforms ...

The 128,000?sq?ft GMP facility is purpose-built for manufacturing high-quality plasmid DNA and viral vectors, including adeno-associated virus (AAV) and lentiviral vector (LVV) platforms, reflecting ...

EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide. For more ...

About Vector BioMed Vector BioMed is a public benefit corporation redefining lentiviral vector manufacturing for accessible, affordable cell and gene therapies.

OXB completes acquisition of remaining stake in US subsidiary Progression to full ownership aligns with global strategy and ...